$NOTE

FiscalNote Holdings, Inc. (NOTE) Reports Q3 Loss, Lags Revenue Estimates

FiscalNote Holdings, Inc. (NOTE) delivered earnings and revenue surprises of -105.95% and -0.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published Nov 7, 2025, 12:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 7, 2025, 2:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FiscalNote Holdings, Inc. (NOTE) Reports Q3 Loss, Lags Revenue Estimates — source image
Decision brief

The 30-second read

$NOTEBearishMed
01

Why it matters

The earnings miss may lead to short-term stock price decline, increased volatility, and reassessment of growth prospects by investors.

02

Market read

While the company's recent performance is weak, its low relevance score suggests limited influence on broader market indices or sector ETFs.

03

What to watch

Potential for operational improvements or strategic announcements that could mitigate negative sentiment in the upcoming quarters

Timing: Immediate, given recent earnings release

Background

FiscalNote Holdings, Inc. reported Q3 earnings significantly below expectations, with a loss of approximately -105.95% and revenue lagging estimates by -0.32%. The company operates in the data and technology sector, providing legal and regulatory data solutions.

Company-level read

Ticker impact

$NOTEBearishMedium confidence
Context

Primary focus due to recent earnings report

Expected impact

Moderate decline expected in the near term, with potential for continued volatility.

Evidence & confidence

The substantial earnings miss and revenue lag are typical catalysts for short-term price declines. However, the low relevance score (0.395) indicates limited impact on broader market sentiment or sector.

Market effects

Potential negative sentiment in the technology and data services sectors

Limited regional impact; primarily company-specific

Minimal, as the company is relatively small and sector-specific

Counterpoint

The stock may have already priced in the earnings disappointment; a rebound could occur if the company provides positive guidance or if market sentiment shifts

Key entities

  • FiscalNote Holdings, Inc.

    A provider of data and technology solutions for legal and regulatory compliance.

Related articles

$NOTEMed

FiscalNote Holdings, Inc. (NOTE): Results of Operations and Financial Condition

FiscalNote Holdings, Inc. (NOTE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 note-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FiscalNote Reports Second Quarter 2026 Financial Results Total Revenue In Line with Guidance; Adjusted EBITDA Slightly Below Guidance; Establishes Q3 2026 Forecast and Revises FY26 Guidance Company To Host Conference Call Tod

$BKRMed

Baker Hughes to Supply Subsea Systems for Kutei Northern Hub

Baker Hughes said it won a contract to supply subsea production systems and digital solutions for the Kutei Northern Hub offshore Indonesia. The deal with Searah North Ganal, a subsidiary of Searah Limited (JV of Eni and Petronas), covers 17 deepwater horizontal tree systems plus manifolds, control and distribution equipment, and Cordant asset protection and condition monitoring.

$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.